Oxford BioDynamics Plc (LON:OBD – Get Free Report) shot up 14% during mid-day trading on Thursday . The company traded as high as GBX 0.60 ($0.01) and last traded at GBX 0.57 ($0.01). Approximately 34,066,758 shares traded hands during mid-day trading, an increase of 12% from the average daily volume of 30,503,400 shares. The stock had previously closed at GBX 0.50 ($0.01).
Oxford BioDynamics Trading Up 15.0 %
The company has a current ratio of 0.68, a quick ratio of 2.80 and a debt-to-equity ratio of 370.22. The firm has a market capitalization of £10.84 million, a price-to-earnings ratio of -0.10 and a beta of 0.42. The firm’s 50-day moving average is GBX 0.85 and its 200 day moving average is GBX 2.50.
About Oxford BioDynamics
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Further Reading
- Five stocks we like better than Oxford BioDynamics
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Fastenal : Growth Trends, Challenges & Key Investment Insights
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 2 Auto Stocks to Let Go and 1 Worth Buying for the Long Haul
- Insider Trading – What You Need to Know
- Biogen Stock Is Mutating Into a Value Play
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
